Organisation paid for research Program year 2025 Source: CMS Open Payments

Advanced Discovery Research

Neither a doctor nor a teaching hospital

Research payments

$41,984

44 payments

Through program year 2025, Advanced Discovery Research is reported as receiving $41,984 in research payments, across 44 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$37,911	3
2024	Research	$969	12
2023	Research	$3,104	29

Breakdown

Who paid Research payments · program years 2023–2025

E.R. Squibb & Sons, L.L.C. $20,236 2 payments
Celgene Corporation $17,675 1 payment
Sumitomo Pharma America, Inc. $4,073 41 payments

Studies the money was for Research payments · program years 2023–2025

A Phase 2, Randomized, Double-blind, Three-Arm, Placebo-controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of orally administered BMS-986368, a FAAH/MAGL Inhibitor, for the treatment of Agitation in Participants with Alzheimer's Disease $35,282 2 payments
A Clinical Study That Will Evalute How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antisychotic Medication $3,104 29 payments
A Phase 2, Randomized, Double-blind, Three-Arm, Placebo-controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of orally administered BMS-986368, a FAAH/MAGL Inhibitor, for the treatment of Agitation in Participants with Alzheimer's Disease $2,629 1 payment
A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication $969 12 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.